Read More

Fertility Solutions-Focused Progyny Stock Sinks After Soft Guidance; Analyst Says ‘Can No Longer Underwrite Sustained Healthy Growth In Forecasts’

Progyny reported first-quarter sales of $278.1 million, slightly below expectations due to increased clients and covered lives. KeyBanc Capital Markets downgraded Progyny from Overweight to Sector Weight, citing concerns about revenue visibility and customer behavior.

PGNY